Stocktoria
Convatec Group PLC CTEC.L
GB · London Stock Exchange · XLON · stock · Healthcare · website
Convatec Group PLC financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $2.4B | $2.3B | $2.1B | $2.1B |
| Gross profit | $1.4B | $1.3B | $1.2B | $1.1B |
| R&D expense | $111.0M | $112.0M | $110.0M | $92.0M |
| SG&A expense | $874.0M | $840.0M | $825.4M | $790.8M |
| Operating income | $386.0M | $332.0M | $265.2M | $221.1M |
| Interest expense | $62.0M | $74.0M | $73.3M | $49.1M |
| Income tax | $55.0M | $55.0M | $37.1M | $19.0M |
| Net income | $175.0M | $191.0M | $130.3M | $62.9M |
| EPS (diluted) | $0.09 | $0.09 | $0.06 | $0.03 |
| Operating cash flow | $470.0M | $397.0M | $367.4M | $281.7M |
| Free cash flow | $285.0M | $275.0M | $238.2M | $137.5M |
| Cash & equivalents | $68.0M | $65.0M | $97.6M | $143.8M |
| Inventory | $416.0M | $349.0M | $396.1M | $336.9M |
| Total assets | $3.8B | $3.5B | $3.7B | $3.6B |
| Total liabilities | $2.3B | $1.8B | $2.0B | $2.0B |
| Shareholders' equity | $1.5B | $1.7B | $1.7B | $1.6B |
Growth · year-over-year · Revenue CAGR 5.6%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +6.6% | +6.8% | +3.4% | — |
| Net income growth | -8.4% | +46.6% | +107.2% | — |
| EPS growth | -7.5% | +47.6% | +103.2% | — |
| Free cash flow growth | +3.6% | +15.4% | +73.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · GB · as of 2025-12-31. Figures in GBp; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.